baclofen has been researched along with Dyskinesia, Medication-Induced in 35 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " I report a patient who developed the syndrome during treatment for schizophrenia with the antipsychotic agent molindone hydrochloride." | 7.68 | Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen. ( Sandyk, R, 1990) |
| " I report a patient who developed the syndrome during treatment for schizophrenia with the antipsychotic agent molindone hydrochloride." | 3.68 | Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen. ( Sandyk, R, 1990) |
| "One patient developed withdrawal symptoms after baclofen was stopped, and the other developed a manic attach while receiving the drug." | 2.37 | Baclofen-induced psychosis: two cases and a review. ( Iskandar, HL; Yassa, RY, 1988) |
| " The trouble occurs or is worsened when neuroleptics are withdrawn and is reduced when dosage is increased; it responds to the theoretical model of denervation supersensitivity." | 2.36 | [Tardive dyskinesia induced by neuroleptics. A review of the literature]. ( Cottereau, MJ; Deniker, P; Diepart, E, 1979) |
| "Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures." | 1.34 | Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities. ( Brahm, NC; Brown, RC; McElwain, DL, 2007) |
| "Treatment with baclofen (4 mg/kg) did not modify spontaneous VCM." | 1.33 | Effects of baclofen on reserpine-induced vacuous chewing movements in mice. ( Abílio, VC; Castro, JP; Frussa-Filho, R; Fukushiro, DF; Medrano, WA; Ribeiro, Rde A; Silva, RH, 2006) |
| "When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal." | 1.32 | Adverse effects of dopamine potentiation by long-term treatment with selegiline. ( Hollán, S; Magyar, K; Vécsei, L, 2004) |
| "Baclofen was also useful in one monkey against a more dystonic form of dyskinesia." | 1.29 | Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys. ( Bédard, PJ; Gomez-Mancilla, B, 1993) |
| "Baclofen (Lioresal) is a derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)." | 1.29 | Baclofen-induced dyskinesia. ( Blumenthal, FS; Ryan, DM, 1993) |
| "Tardive dystonia is an uncommon, disabling side effect of antipsychotic medication that is generally believed to be resistant to treatment." | 1.28 | Tardive dystonia: four case histories. ( Korn, ML; Simpson, GM; Yadalam, KG, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (68.57) | 18.7374 |
| 1990's | 5 (14.29) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 2 (5.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alabed, S | 1 |
| Latifeh, Y | 1 |
| Mohammad, HA | 1 |
| Bergman, H | 1 |
| Niehaus, MT | 1 |
| Elliott, NC | 1 |
| Katz, KD | 1 |
| Hollán, S | 1 |
| Vécsei, L | 1 |
| Magyar, K | 1 |
| Peixoto, MF | 1 |
| Araujo, NP | 1 |
| Silva, RH | 2 |
| Castro, JP | 2 |
| Fukushiro, DF | 2 |
| Faria, RR | 1 |
| Zanier-Gomes, PH | 1 |
| Medrano, WA | 2 |
| Frussa-Filho, R | 2 |
| Abílio, VC | 2 |
| Ribeiro, Rde A | 1 |
| Brahm, NC | 1 |
| McElwain, DL | 1 |
| Brown, RC | 1 |
| Liebman, J | 1 |
| Neale, R | 1 |
| Stewart, RM | 1 |
| Rollins, J | 1 |
| Beckham, B | 1 |
| Roffman, M | 2 |
| Tegeler, J | 1 |
| Wöller, W | 1 |
| Andrade, LA | 1 |
| Bertolucci, PH | 1 |
| Pereira, JS | 1 |
| Marsden, CD | 1 |
| Sheehy, MP | 1 |
| Wolf, ME | 2 |
| Keener, S | 1 |
| Mathis, P | 1 |
| Mosnaim, AD | 2 |
| Nair, NP | 2 |
| Lal, S | 1 |
| Schwartz, G | 2 |
| Thavundayil, JX | 1 |
| Almy, G | 1 |
| Toll, M | 1 |
| Rastogi, SK | 1 |
| Rastogi, RB | 1 |
| Lapierre, YD | 1 |
| Singhal, RL | 1 |
| Häggström, JE | 1 |
| Feder, R | 1 |
| Moore, DC | 2 |
| Gomez-Mancilla, B | 1 |
| Bédard, PJ | 1 |
| Ryan, DM | 1 |
| Blumenthal, FS | 1 |
| Dressler, D | 1 |
| Yassa, R | 2 |
| Ruiz-Navarro, J | 1 |
| Diepart, E | 1 |
| Cottereau, MJ | 1 |
| Deniker, P | 1 |
| Campanini, T | 1 |
| Catalano, A | 1 |
| De Risio, C | 1 |
| Forino, V | 1 |
| Simpson, GM | 2 |
| Lee, JH | 1 |
| Shrivastava, RK | 1 |
| Branchey, MH | 1 |
| Lees, AJ | 1 |
| Shaw, KM | 1 |
| Stern, GM | 1 |
| Gerlach, J | 2 |
| Rye, T | 1 |
| Kristjansen, P | 1 |
| Amsterdam, J | 1 |
| Mendels, J | 1 |
| Yadalam, KG | 1 |
| Korn, ML | 1 |
| Sandyk, R | 2 |
| Nair, V | 1 |
| Dimitry, R | 1 |
| Yassa, RY | 1 |
| Iskandar, HL | 1 |
| Glazer, WM | 1 |
| Bowers, MB | 1 |
| Bunney, BS | 1 |
4 reviews available for baclofen and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Baclofen; Dyskinesia, Drug-Induced; GABA Agonists; gamma-Aminobutyric Acid; Hu | 2018 |
[Tardive dyskinesia: I. Physiopathology and treatment].
Topics: Animals; Antipsychotic Agents; Baclofen; Binding Sites; Dopamine; Dyskinesia, Drug-Induced; Humans; | 1984 |
[Tardive dyskinesia induced by neuroleptics. A review of the literature].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Athetosis; Baclofen; Child; Chorea; Diag | 1979 |
Baclofen-induced psychosis: two cases and a review.
Topics: Acute Disease; Adult; Aged; Baclofen; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Humans; Ma | 1988 |
7 trials available for baclofen and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Baclofen in tardive dyskinesia patients maintained on neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Baclofen; Clinical Trials as Topic; Double-Blind Meth | 1982 |
GABA and movement disorders.
Topics: Anticonvulsants; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; | 1981 |
Baclofen in the treatment of tardive dyskinesia.
Topics: Adult; Aminobutyrates; Antipsychotic Agents; Baclofen; Clinical Trials as Topic; Double-Blind Method | 1978 |
Baclofen in the treatment of tardive dyskinesia and schizophrenia.
Topics: Adult; Aminobutyrates; Baclofen; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; | 1978 |
Baclofen in Parkinson's disease.
Topics: Aged; Aminobutyrates; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu | 1978 |
Effect of baclofen on tardive dyskinesia.
Topics: Aged; Aminobutyrates; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu | 1978 |
The treatment of tardive dyskinesia with baclofen.
Topics: Adolescent; Adult; Aged; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-I | 1985 |
24 other studies available for baclofen and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Baclofen Toxicity Causing Acute, Reversible Dyskinesia.
Topics: Aged, 80 and over; Back Pain; Baclofen; Coronary Artery Disease; Diabetes Mellitus; Drug Interaction | 2016 |
Adverse effects of dopamine potentiation by long-term treatment with selegiline.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Antiparkinson Agents; Baclofen; Basal Ganglia; Bas | 2004 |
Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Baclofen; Behavior, Animal; Diazepam; Dose-Resp | 2005 |
Effects of baclofen on reserpine-induced vacuous chewing movements in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Baclofen; Brain; Brain Chemistry; Dose-Response Relationship, | 2006 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; | 2007 |
Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Baclofen; Basal Ganglia Diseases; Clozapine; Diaz | 1980 |
[Therapeutic measures in tardive dyskinesia].
Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dih | 1983 |
Phenylethylamine-like properties of baclofen.
Topics: Adult; Aged; Baclofen; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; | 1983 |
Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
Topics: Adult; Baclofen; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Halop | 1980 |
Mania associated with the use of baclofen.
Topics: Adult; Affective Disorders, Psychotic; Baclofen; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; | 1982 |
Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia.
Topics: Animals; Baclofen; Brain Chemistry; Disease Models, Animal; Dopamine; Drug Interactions; Dyskinesia, | 1982 |
[Tardive dyskinesia caused by metoclopramide therapy].
Topics: Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Metoclopramide | 1981 |
Baclofen and tardive dyskinesia.
Topics: Baclofen; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged | 1980 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agent | 1993 |
Baclofen-induced dyskinesia.
Topics: Aged; Baclofen; Dyskinesia, Drug-Induced; Humans; Male | 1993 |
Risks of electronic publishing.
Topics: Baclofen; Dyskinesia, Drug-Induced; Dystonia; Humans; Injections, Spinal; Publishing; Word Processin | 1997 |
Tardive dyskinesia.
Topics: Antipsychotic Agents; Baclofen; Benzodiazepines; Choline; Dyskinesia, Drug-Induced; Humans; Pimozide | 1979 |
[Tardive dyskinesia. Synthetic-critical review and case contribution].
Topics: Adult; Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Iatrogenic Disease; Male; Mental Di | 1977 |
Treatment-resistant tardive dyskinesia: a new therapeutic approach.
Topics: Aminobutyrates; Baclofen; Deanol; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ethanolamines | 1979 |
The relationship between parkinsonism and tardive dyskinesia.
Topics: Age Factors; Aminobutyrates; Baclofen; Basal Ganglia; Biperiden; Choline; Dopamine; Dyskinesia, Drug | 1977 |
Tardive dystonia: four case histories.
Topics: Adult; Antipsychotic Agents; Baclofen; Benzodiazepines; Bipolar Disorder; Dyskinesia, Drug-Induced; | 1990 |
Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen.
Topics: Baclofen; Causalgia; Clonazepam; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Humans; | 1990 |
Prevalence of tardive dystonia.
Topics: Adult; Aged; Antipsychotic Agents; Baclofen; Cross-Sectional Studies; Dementia; Drug Therapy, Combin | 1986 |
Orofacial dyskinesia induced by baclofen in a patient with hypothyroidism.
Topics: Baclofen; Dyskinesia, Drug-Induced; Facial Paralysis; Female; Humans; Hypothyroidism; Middle Aged | 1986 |